# Kazia Therapeutics Ltd: Form 6-K, filed Sep 18, 2026

- Company: [Kazia Therapeutics Ltd](/companies/kzia.md) (CIK 1075880)
- Form: 6-K
- Filed: 2026-09-18
- Accepted by EDGAR: Sep 18, 2026, 16:01 ET
- Period: 2026-09-18
- Accession: 0001213900-26-101400
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1075880/000121390026101400/ea030595301-6k_kazia.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1075880/000121390026101400/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1075880/000121390026101400/ea030595301-6k_kazia.htm

Filed Sep 18, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-101400. Last ingested by Listed: Nov 2, 2026, 16:21 ET. No prices; not investment advice.